Unravelling the triglyceride story
Video navigation menu
- Triglycerides are a biomarker for triglyceride-rich lipoproteins 00:31
- The role of lipoprotein lipase in the metabolism of triglyceride-rich lipoproteins 03:14
- Role of triglyceride-rich lipoproteins in arterial inflammation 05:21
This lecture by Peter Libby was part of an accredited symposium "Tackling residual risk beyond LDL-c therapy: The emerging role of EPA & triglycerides" held during the virtual ESC Congress 2021.
Peter Libby is a cardiovascular medicine specialist at Brigham and Women’s Hospital and the Mallinckrodt Professor of Medicine at Harvard Medical School.
This recording was independently developed under auspices of PACE-cme. The views expressed in this recording are those of the individual presenter and do not necessarily reflect the views of PACE-cme.
Funding for this educational program was provided by an unrestricted educational grant received from Amarin.